Dobutamine Hydrochloride Inj · #7 of 35 active shortages by FDA posting duration
Brand: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE
FDA lists Dobutamine Hydrochloride Inj as Active Shortage (Baxter Healthcare).
Availability on file: Available
Dobutamine Hydrochloride Injection: Active Shortage
Available 11 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dobutamine Hydrochloride Injection
- Manufacturer
- Baxter Healthcare
- Dosage Form
- Injection
- Presentation
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)
- Package NDC
- 0338-1073-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Nov 6, 2017
- Last Updated
- Mar 4, 2026
- Therapeutic Category
- Cardiovascular, Pediatric, Renal
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
dobutamine
Side effects, interactions, warnings & more
Nearby, Other Dobutamine Shortage Records
Dobutamine Hydrochloride Injection
Hainan Poly Pharm. Co., Ltd.
Injection
Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection